1 |
Fasano M, Della Corte CM, Papaccio F, et al. Pulmonary large-cell neuroendocrine carcinoma: from epidemiology to therapy[J]. J Thorac Oncol, 2015, 10(8): 1133-1141.
|
2 |
Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases[J]. Am J Surg Pathol, 1991, 15(6): 529-553.
|
3 |
肺神经内分泌肿瘤病理诊断共识专家组. 肺神经内分泌肿瘤病理诊断共识[J]. 中华病理学杂志,2017, 46(1): 9-13.
|
4 |
Derks JL, Hendriks LE, Buikhuisen WA, et al. Clinical features of large cell neuroendocfine carcinoma:a population-based overview[J]. Eur Respir J, 2016, 47(2): 615-624.
|
5 |
Rieber J, Schmitt J, Warth A, et al. Outcome and prog-nostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas[J]. Eur J Med Res, 2015, 20: 64-68.
|
6 |
Li J, Xia T, Zhang W, et al. Primary small cell neuroendocrine carcinoma of the mediastinum: Computed tomography and histopatho-logical correlation[J]. J Comput Assist Tomogr, 2014, 38(2): 174-178.
|
7 |
陈 涛,陈 伟,吴彩云,等. 肺原发性大细胞神经内分泌癌CT与PET-CT表现及病理分析[J]. 临床放射学杂志,2019, 44(6): 1038-1041.
|
8 |
杨 峤,许子寒,郑林鹏. 肺大细胞神经内分泌癌临床特征分析及预后模型建立[J]. 第三军医大学学报,2019, 41(12): 1156-1160.
|
9 |
Derks JL, Van Suylen RJ, Thunnissen E, et al. Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter[J]. Eur Respir J, 2017, 49(6): 1601838.
|
10 |
Hanna N, Johnson D, Temin S, et al. Systemic therapy for stage Ⅳ non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update[J]. J Oncol Pract, 2017, 35(30): 3484-3515.
|
11 |
Hellmann MD, Callahan MK, Awad MM, et al.Tumor mutational burden and efficacy of nivolumab monotherapy and in combination with ipilimumab in small-cell lung cancer[J]. Cancer Cell, 2019, 35(2): 329.
|
12 |
Sherman S, Rotem O, Shochat T, et al. Efficacy of immune check-point inhibtors (ICPi) in large cell neuroendocrine tumors of lung(LCNEC)[J]. Lung Cancer, 2020, 143: 40-46.
|
13 |
Patel SP, Othus M, Chae YK, et al. A phaseⅡbasket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART SWOG 1609) in patients with non-pancreatic neuroendocrine tumors[J]. Clin Cancer Res, 2020, 26(10): 2290-2296.
|
14 |
张瑾瑶,杨 琳,李峻岭. 肺大细胞神经内分泌癌分子标志物的研究进展[J].中国肺癌杂志,2020, 23(11): 983-988.
|
15 |
George J, Walter V, Peifer M, et al. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors[J]. Nat Commun, 2018, 9(1): 1048.
|
16 |
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification [J]. J Thoracic Oncol, 2015, 10: 1243-1260.
|
17 |
朴正华,张慧芝,周新成,等. 肺大细胞神经内分泌癌17例临床病理分析[J]. 临床与实验病理学杂志,2017, 33(9): 1033-1035.
|
18 |
钟文娟,邱 峰,胡丽丽,等. 肺大细胞神经内分泌癌29例临床诊治及预后分析[J]. 广东医学,2014, 35(3): 417-420.
|
19 |
Pelosi G, Rindi G, Travis WD, et al. K- 67 antigen in lung neuroendocrine tumors:unraveling a role in clinical practice[J]. J Thorac Oncol, 2014, 9 (3): 273-284.
|
20 |
郭 健,叶兆祥,冯小伟,等. 肺大细胞神经内分泌癌的MSCT表现[J]. 中国医学影像技术,2013, 29(1): 79-83.
|
21 |
储天晴,韩宝惠,沈 洁,等. 肺大细胞神经内分泌癌14例临床分析[J]. 上海交通大学学报:医学版,2008, 28(9): 1107-1109.
|
22 |
Shin AR, Shin BK, Choi JA, et al. Large cell neuroendocrine carcinoma of the lung, radiologic and pathologic findings[J]. J Comput Assis Tomogr, 2000, 24(4): 567-573.
|
23 |
曾 亮,崔文静,崔 灿,等. 肺少见神经内分泌癌的CT表现[J]. 医学研究生学报,2017, 30(11): 1204-1207.
|
24 |
刘绍信,周永威,刘 健. 肺原发性神经内分泌肿瘤的CT表现[J]. 医学影像学杂志,2014, 24(2): 235-238.
|
25 |
严振辉,柳学国,何亚奇,等. 肺大细胞神经内分泌癌的临床影像学特点与诊断(附22例分析)[J]. 现代医用影像学,2015, 24(3): 375-379.
|
26 |
杨 文,杨 鸿,彭湘晖,等. 多层螺旋CT诊断肺大细胞神经内分泌癌的价值[J]. 放射学实践,2015, 30(4): 342-345.
|
27 |
Takamochi K, Yokose T, Yoshida J, et al. Calcification in large cell neuroendocrine carcinoma of the lung[J]. J Clin Oncol, 2003, 33: 10-13.
|
28 |
李相生,张挽时,熊明辉,等. 周围型肺鳞癌与周围型肺腺癌的螺旋CT动态增强对照[J]. 中华肿瘤杂志,2006, 28(1): 70-73.
|
29 |
Derks JL, Hendriks LE, Buikhuisen WA, et al. Clinical features of large cell neuroendocrine carcinoma: a population-based overview[J]. Eur Respir J, 2016, 47(2): 615-624.
|
30 |
Zhao YZ, Castonguay M, Wilke D, et al. Treatment outcomes and incidence of brain metastases in pulmonary large cell neuroendocrine carcinoma[J]. Curr Probl Cancer, 2019, 43(1): 54-65.
|